China has recently reclassified repeated low level red light (RLRL) devices for use in myopia treatment from Class II to Class III,1as reported by

Optometry Australia has responded swiftly to early results from a survey of over 500 optometrists practising in Australia, updating its position statement on Appropriate

Optometrists are increasingly interested in integrating artificial intelligence (AI) into glaucoma care, taking advantage of the technology’s capability to enhance diagnostic accuracy, track disease

Optometry Australia (OA) has welcomed changes to Medicare rebates that come into effect on 1 March 2025, but says there is more to be